Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Clinical trial NCT06699394 · RECRUITING
Trial details
- NCT number
- NCT06699394
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-29
- Primary completion
- 2025-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.